Innovent Biologics Inc (1801.HK) stock: key figures, P/E, revenue and dividend
Health Care · China · ISIN KYG4818G1010
Innovent Biologics Inc financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 9.42 bn CNY | 13.58 bn CNY |
| Gross profit | 7.91 bn CNY | 10.41 bn CNY |
| EBIT | -755.00 m CNY | 763.50 m CNY |
| Net income | -94.00 m CNY | 846.75 m CNY |
| Diluted EPS – continuing operations | -0.06 CNY | 0.47 CNY |
Full history since 2016, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Innovent Biologics Inc
Innovent Biologics, Inc., a biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People's Republic of China, the United States, Europe, and internationally. The company discovers, develops, manufactures, and commercializes monoclonal antibodies and other drugs for the treatment of oncology, ophthalmology, autoimmune, cardiovascular, and metabolic diseases. Its commercial stage product portfolio includes TYVYT (sintilimab injection), BYVASDA (bevacizumab injection), SULINNO (adalimumab injection), HALPRYZA (rituximab injection), PEMAZYRE (pemigatinib), olverembatinib, Cyramza (ramucirumab), Retsevmo (selpercatinib), FUCASO (Equecabtagene Autoleucel), SINTBILO (tafolecimab injection), DUPERT (fulzerasib), DOVBLERON (taletrectinib adipate), Jaypirca (pirtobrutinib), limertinib, SYCUME (teprotumumab N01 injection), mazdutide, PECONDLE (picankibart injection), and TABOSUN(Ipilimumab N01 injection). In addition, it sells and distributes pharmaceutical products; and offers consultation and research and development services. The company was incorporated in 2011 and is headquartered in Suzhou, the People's Republic of China.
More stocks
- Permian Resources Corp (PR)
- Bank of Ireland Group PLC (BIRG.IR)
- Beiersdorf (BEI.DE)
- Amrize Ltd (AMRZ)
- Aspeed Technology (5274.TWO)
- Viatris (VTRS)
- Lens Technology Co Ltd (300433.SZ)
- Yuanjie Semiconductor Technology Co. Ltd. A (688498.SS)
- Santander Bank Polska SA (SPL.WA)
- Shenzhen Inovance Tech (300124.SZ)
- LyondellBasell (LYB)
- Aeon Co Ltd (8267.T)
Not investment advice. All data without warranty, price as of 15.10.2026. Details in the risk notice.